News
Apply for Supplemental Funds to Support Collaborations Concerning the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences
The National Cancer Institute is participating in a Notice of Special Interest (NOSI) designed to provide supplemental funds to active NIH grants with a significant artificial intelligence/machine learning (AI/ML) and/or ethics component. Namely, the funds will support collaborations for advancing the understanding, tools, metrics, and practices for the ethical development and use of AI/ML in biomedical and behavioral research. Applications must be submitted by March 31, 2022, at 5:00 p.m. (local time of applicant organization).
Refer to the NOSI for full details on submission information and eligibility criteria.
Note: Not all participating NIH Institutes and Centers (ICs) support all the activity codes that may otherwise be allowed. Applicants are therefore strongly encouraged to consult the program officer of the parent grant to confirm eligibility.
The initiative is aligned with the NIH Strategic Plan for Data Science, which describes actions aimed at modernizing the biomedical research data ecosystem and making data FAIR (Findable, Accessible, Interoperable, and Reusable) with high impact for open science.
It is the NIH vision to establish a modernized and integrated biomedical data ecosystem that adopts the latest data science technologies, including AI and ML, and best practice guidelines arising from community consensus, such as the FAIR principles, and open-source development. This effort is led by the NIH Office of Data Science Strategy.